HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Haemanthus coccineus extract and its main bioactive component narciclasine display profound anti-inflammatory activities in vitro and in vivo.

Abstract
Haemanthus coccineus extracts (HCE) have traditionally been used to treat a variety of diseases, like febrile colds or asthma. Since new therapeutic options against inflammatory processes are still urgently needed, we aimed to pharmacologically characterise the anti-inflammatory potential of HCEin vitro and in vivo and to identify the underlying bioactive component(s). The action of HCE on oedema formation and leucocyte infiltration were analysed in two murine models of inflammation (dermal oedema induced by arachidonic acid and croton oil; kidney injury caused by unilateral ureteral obstruction). The interaction of leucocytes with endothelial cells (ECs) as well as the activation parameters of these two cell types were analysed. Moreover, the nuclear factor κB (NFκB) pathway was investigated in detail in ECs. Using different fractions of HCE, the bioactive principle was identified. In vivo, HCE (450 mg/kg orally or 2 mg/kg intraperitoneally) inhibited oedema formation, leucocyte infiltration and cytokine synthesis. In vitro, HCE (100-300 ng/ml) blocked leucocyte-EC interaction as well as the activation of isolated leucocytes (cytokine synthesis and proliferation) and of primary ECs (adhesion molecule expression). HCE suppressed NFκB-dependent gene transcription in the endothelium, but did not interfere with the NFκB activation cascade (IκB degradation, p65 nuclear translocation and NFκB DNA-binding activity). The alkaloid narciclasine was elucidated as the bioactive compound responsible for the anti-inflammatory action of HCE. Our study highlights HCE and its main alkaloid narciclasine as novel interesting approach for the treatment of inflammation-related disorders.
AuthorsSimone Fuchs, Louise T Hsieh, Werner Saarberg, Clemens A J Erdelmeier, Thomas A Wichelhaus, Liliana Schaefer, Egon Koch, Robert Fürst
JournalJournal of cellular and molecular medicine (J Cell Mol Med) Vol. 19 Issue 5 Pg. 1021-32 (May 2015) ISSN: 1582-4934 [Electronic] England
PMID25754537 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.
Chemical References
  • Amaryllidaceae Alkaloids
  • Anti-Inflammatory Agents
  • Cell Adhesion Molecules
  • Chemokine CCL2
  • NF-kappa B
  • Phenanthridines
  • Plant Extracts
  • Arachidonic Acid
  • narciclasine
  • Croton Oil
Topics
  • Amaryllidaceae Alkaloids (pharmacology)
  • Animals
  • Anti-Inflammatory Agents (pharmacology)
  • Arachidonic Acid
  • Blotting, Western
  • Cell Adhesion (drug effects)
  • Cell Adhesion Molecules (metabolism)
  • Cell Line, Tumor
  • Cells, Cultured
  • Chemokine CCL2 (biosynthesis)
  • Croton Oil
  • Edema (chemically induced, prevention & control)
  • Endothelial Cells (cytology, drug effects, metabolism)
  • Humans
  • Leukocytes (cytology, drug effects, metabolism)
  • Liliaceae (chemistry)
  • Macrophages (drug effects, metabolism)
  • Male
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Microscopy, Fluorescence
  • NF-kappa B (metabolism)
  • Neutrophil Infiltration (drug effects)
  • Phenanthridines (pharmacology)
  • Plant Extracts (pharmacology)
  • Signal Transduction (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: